I am a medical oncologist who specializes in treating gastrointestinal malignancies, such as esophageal cancers, colorectal cancers and hepatopancreaticobiliary tract cancers, which include cancers of the pancreas, ampulla, liver and biliary tract. I believe in a precision approach to cancer care using the latest technology, like genetic testing of tissue and/or blood, as well as non-chemotherapy options if possible. Even in stage IV cancers, I try to be aggressive when needed if I think there is a chance to cure. I work with a multidisciplinary team of like-minded colleagues who are equally aggressive and take a patient-centric approach in order to deliver the best possible care. The OSUCCC – James offers a wide range of clinical trials for patients to enroll in that can be beneficial as well. In addition to my clinical duties, I am a member of the Translational Therapeutics Program, where my research focuses on the predictive and prognostic markers of hepatobiliary and pancreatic cancers, as well as exploring the role of the microbiome in the treatment response for these cancers. I am also interested in addressing clinicopathological risk factors that help predict immune-related adverse events and ways to overcome them. My current research projects focuses on new biomarkers in blood for managing pancreatic cancers. I am leading a clinical trial to treat biliary tract cancers (cholangiocarcinoma) with novel drugs and pancreatic cancer with electromagnetic fields. My work has been published in such peer-reviewed journals as Cancers, Frontiers in Oncology, and Frontiers in immunology, and as book chapters. The thing I enjoy most about working at the OSUCCC – James is that there are experts in every field who are always willing to collaborate. I also have the opportunity to engage in clinical and basic research to help in pushing the boundaries of cancer care and treatment, with the ultimate goal of creating a cancer-free world.